The global Gemigliptin Market is estimated to be valued at US$ 1.79 Billion In 2023 and is expected to exhibit a CAGR Of 5.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Gemigliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. It helps in reducing blood sugar levels by inhibiting the enzyme responsible ... Read more
